The Effect of Astragalus fasciculifolius and Phenytoin Cream on pain and episiotomy wound healing

Phase 3

Recruiting

• Conditions: Condition 1: Pain severity. Condition 2: Wound healing.; Other acute post procedural pain; Disruption of peritoneal obstetric wound; G89.18; O90.1

• Registration Number: IRCT20220816055724N3
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Normal pregnancy and delivery
primiparous
Age between 15-45
Having at least reading and writing literacy
Body mass index (after delivery) between 18.5-30 kilograms per square meter

Exclusion Criteria

Gestational age below 37 or above 42 weeks
Multiple pregnancy
Fetus Malpresentation
Suffering from diseases that interfere with wound healing such as: anemia, infection and perineum wounds, diabetes, High blood pressure, diseases of skin, heart, kidney, lung , coagulation disorder, immunodeficiency, hemophilia, disorder of connective tissue, depression, malnutrition, mental illnesses, cancer)
Using drugs effective on wound healing such as: anticoagulants, antidepressants, antiepileptics), glucocorticoids, immune system suppressors, antibiotics, narcotics and psychotropic drugs, chemotherapy
Rupture of Amionitic membran more than 18 hours
Instrumental vaginal delivery or non-medial or lateral episiotomy incision
Non spontaneous removal of the placenta
History of previous injury or surgery or visible lesions in the perineum such as: genital warts, hemorrhoids
Alcohol drinking or smoking
Persistent constipation (according to the mother statement )

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Days1, 5 and 10 after delivery. Method of measurement: Visual analog scale (VAS).;Episiotomy wound healing. Timepoint: Days1, 5 and 10 after delivery. Method of measurement: Reeda Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Drug side effect. Timepoint: Days 5 and 10 after delivery. Method of measurement: questionnaire.